Winters Chad's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Dec 5, 2023
- Accession no.
- 0001127602-23-028965
- Filed
- Dec 5, 2023
- Trade date
- Dec 1, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $353.5K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001127602-23-030255 (Dec 21, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Winters ChadCIK 0001811424 | Officer (VP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | Common Stock | MOption exerciseAcquired | +456 | $143.43 | +$65,404.08 | 1,941.7 | Direct | |
| Dec 1, 2023 | Common Stock | SSaleDisposed | −1,013 | $349.00 | −$353,537 | 1,269.7 | Direct | |
| Dec 1, 2023 | Common Stock | MOption exerciseAcquired | +341 | $173.22 | +$59,068.02 | 2,282.7 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | Stock Options (Right to Buy) | MOption exerciseDisposed | −456 | $0.00 | $0 | 0 | Direct | |
| Dec 1, 2023 | Stock Options (Right to Buy) | MOption exerciseDisposed | −341 | $0.00 | $0 | 1,571 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.